Tower Research Capital (TRC)’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-100
Closed -$221 6377
2023
Q2
$221 Buy
+100
New +$221 ﹤0.01% 5706
2022
Q4
Sell
-3,768
Closed -$10K 6638
2022
Q3
$10K Buy
3,768
+2,443
+184% +$6.48K ﹤0.01% 4607
2022
Q2
$3K Sell
1,325
-10,433
-89% -$23.6K ﹤0.01% 5454
2022
Q1
$35K Sell
11,758
-857
-7% -$2.55K ﹤0.01% 3019
2021
Q4
$56K Sell
12,615
-12,921
-51% -$57.4K ﹤0.01% 2689
2021
Q3
$124K Sell
25,536
-6,227
-20% -$30.2K ﹤0.01% 2214
2021
Q2
$217K Buy
31,763
+23,579
+288% +$161K 0.01% 1859
2021
Q1
$58K Sell
8,184
-3,665
-31% -$26K ﹤0.01% 3000
2020
Q4
$75K Sell
11,849
-33,018
-74% -$209K ﹤0.01% 2649
2020
Q3
$243K Buy
44,867
+37,786
+534% +$205K ﹤0.01% 2390
2020
Q2
$37K Buy
+7,081
New +$37K ﹤0.01% 3291
2019
Q3
Sell
-2,174
Closed -$9K 4646
2019
Q2
$9K Buy
2,174
+578
+36% +$2.39K ﹤0.01% 2641
2019
Q1
$9K Buy
+1,596
New +$9K ﹤0.01% 2762
2018
Q3
Sell
-1,014
Closed -$11K 4377
2018
Q2
$11K Sell
1,014
-432
-30% -$4.69K ﹤0.01% 2753
2018
Q1
$19K Buy
+1,446
New +$19K ﹤0.01% 2204
2017
Q4
Sell
-3,258
Closed -$82K 4265
2017
Q3
$82K Buy
3,258
+3,204
+5,933% +$80.6K 0.01% 1561
2017
Q2
$1K Sell
54
-52
-49% -$963 ﹤0.01% 2537
2017
Q1
$2K Buy
+106
New +$2K ﹤0.01% 2693
2016
Q4
Sell
-100
Closed -$1K 4557
2016
Q3
$1K Sell
100
-1,472
-94% -$14.7K ﹤0.01% 3414
2016
Q2
$22K Buy
1,572
+1,111
+241% +$15.5K ﹤0.01% 2169
2016
Q1
$7K Buy
461
+261
+131% +$3.96K ﹤0.01% 2425
2015
Q4
$4K Sell
200
-1,361
-87% -$27.2K ﹤0.01% 3285
2015
Q3
$30K Buy
+1,561
New +$30K ﹤0.01% 1404
2015
Q1
Sell
-227
Closed -$9K 5093
2014
Q4
$9K Sell
227
-446
-66% -$17.7K ﹤0.01% 2267
2014
Q3
$16K Buy
673
+588
+692% +$14K ﹤0.01% 2498
2014
Q2
$2K Sell
85
-29
-25% -$682 ﹤0.01% 3487
2014
Q1
$4K Sell
114
-33
-22% -$1.16K ﹤0.01% 3489
2013
Q4
$6K Sell
147
-137
-48% -$5.59K ﹤0.01% 3439
2013
Q3
$11K Sell
284
-199
-41% -$7.71K ﹤0.01% 3163
2013
Q2
$18K Buy
+483
New +$18K ﹤0.01% 1832